China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter Study of Predicting Renal Cancer Subtypes Using Pathomics of Biopsy Specimens Combined with Radiomics'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131629
Registration Time: 2026/09/04
Type: Diagnostic test
Primary Sponsor: The Third Medical Centre, Chinese PLA General Hospital, Beijing, China
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337229
Published by HT Digital Content Services with permission from Health Daily Digest....